Skip to search formSkip to main contentSkip to account menu

capuramycin

Known as: beta-D-Allofuranuronamide, 1-deoxy-5-O-(4-deoxy-N-(hexahydro-2-oxo-1H-azepin-3-yl)-alpha-L-erythro-hex-4-enopyranuronamidosyl)-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, (S)- 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Aminoglycosides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Biosynthetic and Synthetic Strategies for Assembling Capuramycin-Type Antituberculosis Antibiotics
Mycobacterium tuberculosis (Mtb) has recently surpassed HIV/AIDS as the leading cause of death by a single infectious agent. The… 
2018
2018
Natural Products as Immune System Modulators, and Against Infections of the Central Nervous System
2012
2012
A new protecting group and linker for uridine ureido nitrogen.
2010
2010
Functional and Kinetic Analysis of the Phosphotransferase CapP Conferring Selective Self-resistance to Capuramycin Antibiotics*
Capuramycin-related compounds, including A-500359s and A-503083s, are nucleoside antibiotics that inhibit the enzyme bacterial… 
2009
2009
Concise synthesis of capuramycin.
A concise total synthesis of capuramycin (1), a promising preclinical TB drug lead, is achieved by high-yield formations of the… 
2008
2008
Enhancement of Intracellular Activity of Capuramycin (CM) Analogue SQ641 Against M. tuberculosis (MTB)
2007
2007
A-102395, a New Inhibitor of Bacterial Translocase I, Produced by Amycolatopsis sp. SANK 60206
Bacterial phospho-N-acetylmuramyl-pentapeptide translocase (translocase I: EC 2.7.8.13) is a key enzyme in peptidoglycan… 
2004
2004
A-503083 A, B, E and F, novel inhibitors of bacterial translocase I, produced by Streptomyces sp. SANK 62799.
Novel nucleoside antibiotics were isolated from the cultured broth of the strain classified as Streptomyces sp. SANK 62799. The… 
2003
2003
Studies on novel bacterial translocase I inhibitors, A-500359s. III. Deaminocaprolactam derivatives of capuramycin: A-500359 E, F, H; M-1 and M-2.
Novel derivatives of capuramycin were obtained when 10 mM of 2-aminoethyl-L-cysteine (AEC), an inhibitor of aspartokinase, was… 
2003
2003
Studies on novel bacterial translocase I inhibitors, A-500359s. I. Taxonomy, fermentation, isolation, physico-chemical properties and structure elucidation of A-500359 A, C, D and G.
In the course of our screening for bacterial phospho-N-acetylmuramyl-pentapeptide-translocase (translocase I: EC 2.7.8.13… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)